- Home
- OCGN vs OLMA Comparison
OCGN vs OLMA Comparison
Compare OCGN & OLMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OCGN
- OLMA
- Stock Information
- Founded
- OCGN 2013
- OLMA 2006
- Country
- OCGN United States
- OLMA United States
- Employees
- OCGN N/A
- OLMA N/A
- Industry
- OCGN Biotechnology: Biological Products (No Diagnostic Substances)
- OLMA Biotechnology: Pharmaceutical Preparations
- Sector
- OCGN Health Care
- OLMA Health Care
- Exchange
- OCGN Nasdaq
- OLMA Nasdaq
- Market Cap
- OCGN 278.3M
- OLMA 299.7M
- IPO Year
- OCGN N/A
- OLMA 2020
- Fundamental
- Price
- OCGN $1.06
- OLMA $4.20
- Analyst Decision
- OCGN Strong Buy
- OLMA Strong Buy
- Analyst Count
- OCGN 3
- OLMA 4
- Target Price
- OCGN $6.00
- OLMA $24.50
- AVG Volume (30 Days)
- OCGN 6.3M
- OLMA 868.7K
- Earning Date
- OCGN 08-07-2025
- OLMA 08-05-2025
- Dividend Yield
- OCGN N/A
- OLMA N/A
- EPS Growth
- OCGN N/A
- OLMA N/A
- EPS
- OCGN N/A
- OLMA N/A
- Revenue
- OCGN $4,522,000.00
- OLMA N/A
- Revenue This Year
- OCGN N/A
- OLMA N/A
- Revenue Next Year
- OCGN N/A
- OLMA N/A
- P/E Ratio
- OCGN N/A
- OLMA N/A
- Revenue Growth
- OCGN N/A
- OLMA N/A
- 52 Week Low
- OCGN $0.52
- OLMA $2.86
- 52 Week High
- OCGN $1.98
- OLMA $16.62
- Technical
- Relative Strength Index (RSI)
- OCGN 59.49
- OLMA 43.60
- Support Level
- OCGN $1.10
- OLMA $3.90
- Resistance Level
- OCGN $1.29
- OLMA $4.29
- Average True Range (ATR)
- OCGN 0.10
- OLMA 0.36
- MACD
- OCGN -0.00
- OLMA -0.03
- Stochastic Oscillator
- OCGN 53.06
- OLMA 19.18
About OCGN Ocugen Inc.
Ocugen Inc company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve health and offer hope for patients across the globe. The company's pipeline includes Modifier Gene Therapy Platform, Novel Biologic Therapy for Retinal Diseases, Regenerative Medicine Cell Therapy Platform, Inhaled Mucosal Vaccine Platform. The company is developing a modifier gene therapy platform designed to fulfill unmet medical needs related to retinal diseases, including inherited retinal diseases ("IRDs"), such as RP, LCA, Stargardt disease, and multifactorial diseases such as dAMD and Geographic Atrophy ("GA").
About OLMA Olema Pharmaceuticals Inc.
Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.